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Appropriate therapeutic modulation of endothelial proliferation and sprouting is essential for
the effective inhibition of angiogenesis in cancer or its induction in cardiovascular disease.
The current view is that an increase in growth factor concentration, and the resulting
mitogenic activity, increases both endothelial proliferation and sprouting. Here, we modulate
mitogenic stimuli in different vascular contexts by interfering with the function of the VEGF
and Notch signalling pathways at high spatiotemporal resolution in vivo. Contrary to the
prevailing view, our results indicate that high mitogenic stimulation induced by VEGF, or
Notch inhibition, arrests the proliferation of angiogenic vessels. This is due to the existence of
a bell-shaped dose-response to VEGF and MAPK activity that is counteracted by Notch and
p21, determining whether endothelial cells sprout, proliferate, or become quiescent. The
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B lood vessel formation requires tight coordination of mole-cular and cellular processes to ensure that new endothelialcells (ECs) are generated at the right time, pace and place.
Numerous studies conducted in embryos, organs, and tumours
have established the importance for angiogenesis of the VEGF
and Dll4/Notch signalling pathways1–8.
Growing or hypoxic tissues secrete vascular endothelial growth
factor (VEGF). Activation of VEGFR2, the most important VEGF
receptor, then triggers a series of phosphorylation cascades,
including ERK (MAPK) activation, that are considered essential
for EC motility and proliferation. The ECs at the tip of the vas-
cular front, and closest to the source of VEGF, express higher
levels of several genes, including Esm1, Angpt2 and the Notch
ligand Dll49,10, giving them a distinct molecular signature from
that of adjacent stalk cells. Notch activity is thought to be rela-
tively higher in stalk cells and inhibits endothelial sprouting and
proliferation, and is therefore assumed to be a negative regulator
of VEGF function in these cells. Tip-cell specification and EC
proliferation are two related processes considered to be positively
regulated by VEGF and negatively regulated by Notch. According
to this model, tip cells should proliferate more than stalk cells
because they have higher-VEGF signalling and lower-Notch sig-
nalling. However, in vivo studies suggested that tip cells do not
proliferate, or proliferate much less than stalk cells11,12. In con-
trast to these findings, live imaging during zebrafish interseg-
mental vessels development showed that in some contexts tip
cells can divide equally as well as stalk cells, while migrating and
sprouting4. The inter-regulation of EC sprouting and prolifera-
tion dynamics by VEGF and Notch has been difficult to adjust to
a simple model in which actively sprouting ECs do not pro-
liferate, since these cells receive the highest VEGF stimulus and
are thought to have low-Notch signalling, two conditions believed
to be pro-mitogenic.
Here, we use inducible fluorescent genetic mosaic (ifgMosaic)
mouse lines13 and different pharmacological treatments to define
at high cellular and temporal resolution the role of the Notch and
VEGF signalling pathways in the proliferative behaviour of ECs.
This approach reveals that ECs have a bell-shaped dose–response
to mitogenic stimuli in vivo that is highly dependent on the vas-
cular developmental context. This is due to a cell-cycle checkpoint
molecular mechanism that is elicited when VEGF stimulation is
high or Notch signalling is low during angiogenesis. In these
conditions, ECs have high-ERK activity, which induces the
expression of the cell-cycle inhibitor p21, and the ensuing cell-
cycle arrest enhances endothelial sprouting and migration, but
ultimately blocks angiogenesis due to the inhibition of endothelial
proliferation. Our study revisits the important role of Notch and
VEGF in the balance of endothelial proliferation and sprouting
during angiogenesis, and provides significantly more molecular,
cellular and temporal resolution on the underlying mechanism.
Results
Angiogenic ECs proliferate less after Notch loss-of-function.
Studies with pharmacological compounds or with classical
knockout or conditional mouse lines revealed that loss-of-
function (LOF) of Dll4, Notch1 or Rbpj results in severe vas-
cular developmental defects and a marked delay in tumour
growth due to an abnormal increase in angiogenesis5,6,11,14–20.
Inhibition of Notch signalling in human venous ECs (HUVECs)
or mouse EC lines increases their proliferation21,22 (see also
Supplementary Fig. 1a, b). However, there is less consensus on the
effect of Notch inhibition on EC proliferation in vivo. Some
groups reported no significant differences in the number of ECs
in s-phase (BrdU+) in retinas of Dll4 heterozygous mice or after
treatment with a general y-secretase inhibitor (DAPT)11,20,
whereas others have seen an increase in the frequency of BrdU+
or Ki67+ ECs in retina vessels of mice treated with different
Notch signalling inhibitors (y-secretase inhibitor or Dll4-Fc
proteins)5,22,23. Live imaging of intersegmental arteries develop-
ment showed an increase in the number of ECs in zebrafish
embryos with a morpholino-induced reduction of Dll4 and Rbpj
expression4.
Rbpj is the main transcription factor that associates with all
four Notch intracellular domains, enabling the Notch-induced
transcriptional programme. To evaluate the effect of full loss of
endothelial Notch signalling, we induced Rbpj deletion in the ECs
of mice carrying the alleles Rbpj floxed24, Cdh5-CreERT225, and
iSuRe-Cre. After tamoxifen induction, full deletion of the Rbpj
gene occurs in MbTomato+ cells (Supplementary Fig. 1c–e). Rbpj
gene deletion in most retina ECs from P1 to P6 induced an
increase in vascular surface density and sprouting; however, at the
same time it significantly decreased the total number of ECs at the
angiogenic front (Fig. 1a–d). These results indicate that an
increase in vascular density and sprouting can be accompanied by
a significant decrease in the number of ECs generated, ultimately
reducing vascular progression and angiogenesis (Fig. 1e). Inter-
estingly, VEGF injection in the retina vitreous was previously
shown to induce vascular expansion, through a process that is
independent of its effect on EC proliferation26.
So far it was not possible to assess the cell autonomous and long-
term consequence of Notch LOF or gain-of-function in embryonic
ECs in vivo, because complete disruption or activation of Notch
signalling in blood vessels strongly affects vascular development and
the physiology of the surrounding tissue, compromising embryonic
development14,15. With this in mind, we used inducible fluorescent
genetic mosaic mouse lines13 that allowed us to interfere with
Notch activity at single-cell resolution and analyse its impact on
long-term EC proliferation and competition in an otherwise normal
(wild-type) environment. These mouse lines are based on the
Brainbow technology27 and viral 2A peptide equimolar bicistronic
gene expression28. In cells with Cre expression or activation of
CreERT2, a stochastic and mutually exclusive recombination event
occurs among the different LoxP sites, generating a fluorescent
mosaic of cells with normal, low (DN-Maml1 or DN-Rbpj+), or
high (NICD-PEST+) Notch activity (Fig. 1f and Supplementary
Fig. 2). Unlike classical conditional knockout genetics, induction
of genetic mosaics with the Tie2-Cre allele29 in ECs at embryonic
day (E) 8.5 was not embryonically lethal. This allowed us to track
the fate and assess the relative proliferation and competitiveness
of ECs with distinct Notch signalling levels over long periods,
from E8.5 to postnatal stages. As expected, ECs with high Notch
signalling levels had impaired proliferation and were gradually lost
during vascular development. Unexpectedly, ECs with a cell-
autonomous decrease in Notch signalling, which are considered to
have higher sprouting and proliferative activity1,2,30, did not win
the vascular growth competition and most vessels in mosaic
animals at postnatal day 20 (P20) were formed from ECs with
normal Notch levels (Fig. 1f and Supplementary Fig. 2).
Notch signalling prevents the arrest of proliferating ECs. To
characterise the role of Dll4/Notch in EC proliferation at higher
temporal resolution, we used a Dll4-blocking antibody5. In con-
trast to inducible genetic deletions (Dll4 or Rbpj genes) or general
pharmacological Notch inhibitors (Dll4-Fc, DAPT or DBZ) used
before5,11,19,20,23, a high dose (10 mg/kg) of anti-Dll4 acutely,
potently and sustainably inhibited the endothelial Dll4-Notch
signalling in the retinal angiogenesis model (Supplementary
Fig. 1f). In this way, we were able to analyse the expression of
several cell-cycle markers in the nuclei (Erg+) of proliferating
ECs from 12 to 72 h after signalling inhibition in vivo (Fig. 2 and
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Fig. 1 ECs with low- or high-Notch signalling are outcompeted during vascular development. a, b Confocal micrographs of the postnatal mouse retina
vasculature showing that the full deletion of the Rbpj gene from P1 to P6 during retina angiogenesis, results in an increase in endothelial surface and
sprouting (isolectinB4) and a decrease in the number of ECs (ERG+) and vascular progression. Cells with deletion of Rbpj from P1 to P3 are usually
not found in arterial and peri-arterial endothelium at P6. See details of the iSuRe-Cre allele in Supplementary Fig. 1c–e. Scale bars, 80 μm. c–e Comparison
of indicated parameters in large microscopic fields of control (n= 5) and mutant (n= 4) mice. f The iChr-Notch-Mosaic and Tie2-Cre mouse lines were
crossed to generate fluorescent and genetic mosaics starting at E8.5 in growing ECs. Tissues of mice (n= 4) aged 20 days (P20) were analysed for
the presence of Cherry, EGFP or HA-Cerulean cells. Comparison of the P20 ratios to the baseline/initial recombination ratio determined in E9.5 embryos
(n= 4) or ES cells (see also Supplementary Fig. 2), shows that ECs with low Notch (EGFP+) or high Notch (HA-Cerulean+) are outcompeted during
vascular development. Error bars indicate StDev; **p < 0.005. Two-tailed unpaired t test. Source data are provided as a Source Data file. Scale bars, 50 μm
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Fig. 2 Dll4/Notch signalling inhibition induces context-dependent proliferative effects. a–d Confocal micrographs of the postnatal retinal vasculature from
animals treated at P5 with IgG (control) or anti-Dll4 for 24 h (a, b) or 48 h (c, d). Anti-Erg (red) labels EC nuclei. EdU labels the nuclei of all cells in S-phase
in the previous 4 h. Blue nuclei mark non-endothelial cells in S-phase, and double-positive (Erg+/EdU+) cell nuclei are pseudocoloured green to better
highlight ECs in S-phase. Scale bars, 200 μm. e–h Comparison of indicated parameters in large microscopic fields of antibody treated retinas (n= 4 mice
per group). Inhibition of Dll4/Notch signalling with anti-Dll4 leads to fast (24 and 48 h) endothelial expansion (number of Erg+ cells per field) followed by
premature cell-cycle exit at the angiogenic front (e, f) and cell-cycle re-entry by mature ECs (g–h), which are indicated by the changes observed in
the frequency of Erg+ cells in S-phase (EdU+). i, j EC-specific deletion of the Dll4 gene from P4 to P7, results in a similar proliferative response. Scale bars,
70 μm. k Comparison of indicated parameters in large microscopic fields of control (n= 3) and mutant (n= 3) mice retinas. Error bars indicate std. dev.;
NS nonsignificant; ***p < 0.0005. One-way ANOVA with Tukey’s post hoc test (e–h) or two-tailed unpaired t test (k). Source data are provided as a Source
Data file
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Supplementary Figs. 3 and 4). This high-resolution comparative
analysis showed that loss of Dll4-Notch activity for 24–48 h leads
to a transient increase in EC number and density (Fig. 2a–e, g)
followed by a pronounced cell-cycle arrest. The fast cellular
expansion observed in angiogenic areas occurred without an
increase in the proportion of EdU+/Erg+ or Ki67+/H2B-GFP+
proliferating ECs (Fig. 2a, b, f and Supplementary Fig. 4 (24 h),
and Supplementary Fig. 3g, h (12 h)). At the angiogenic front
(AF), 96% of ECs were cycling (Ki67+/H2B-GFP+), and this
frequency did not increase 24 h after Notch inhibition; rather, it
decreased slightly (Supplementary Fig. 4b, f). The fast increase in
EC number and density, without an increase in the frequency of
proliferating cells (EdU+/ERG+ or Ki67+/ERG+), can only be
explained by an increase in cell-cycle speed or a decrease in EC
apoptosis. Since we have not detected apoptosis in any EC at the
AF, these results suggest that Notch inhibition at the AF increases
the speed of the EC cycle and not the proportion of proliferating
ECs, in contrast to previous reports4,5,11,20,22,23,31. Importantly,
this burst in vascular expansion was transient, lasting less than 48
h, by which time most ECs with loss of Notch signalling have
already exited the cell cycle (Fig. 2d, f and Supplementary Fig. 4d,
f). In contrast, in vessels of control IgG treated animals, the
slower-dividing ECs, with normal Notch levels, continued to cycle
for longer (Fig. 2c, f and Supplementary Fig. 4d, f), generating
more ECs overtime (more ERG+ ECs per IsolectinB4 area) when
compared with retinas treated with the Dll4-blocking antibody
for 72 h (Supplementary Fig. 3a, b), mimicking the effect of Rbpj
deletion from P1 to P6 (Fig. 1a, b). These results show that
physiological Dll4/Notch activity slows EC proliferation in order
to prevent the premature expansion and exhaustion of cycling
ECs at the AF. Interestingly, Notch inhibition had a distinct effect
in non-proliferative and more mature vessels, which are further
from the source of angiogenic growth factors like VEGF. In
quiescent (G0, Ki67−) retinal vessels, Dll4/Notch inhibition
induced cell-cycle entry (Fig. 2h and Supplementary Fig. 4c, e, g),
which is consistent with the previously described role of Notch as
a suppressor of EC proliferation in mature quiescent adult ves-
sels3. Deletion of Dll4 in ECs (Dll4iDEC) from P4 to P7 resulted in
the same differential effect on the proliferation of angiogenic and
mature ECs (Fig. 2i–k). Thus, our results indicate that if ECs are
angiogenic at the time of Dll4/Notch LOF, they will proliferate
faster but for a very short period, after which they exit the cell
cycle; however, if ECs are quiescent, they reenter the cell cycle
and divide for an extended period of time. This mislocalization of
EC proliferation after Notch inhibition, from the AF to the more
mature vascular area, impairs the growth of vessels into VEGF
rich and hypoxic tissues (Fig. 1e).
High-ERK activation induces EC cycle arrest. We next inves-
tigated the impact of Notch on the activity of the MAPK/ERK
pathway in proliferating (Ki67+) ECs. ERK signalling is known
to induce both EC sprouting and proliferation32–34. We detected
high levels of phospho-ERK (P-ERK) in tip cells (Fig. 3a left), the
cells with the highest VEGF signalling input. In the absence of
Dll4/Notch signalling for 24 h, P-ERK levels increased sig-
nificantly in stalk cells and also in more distal quiescent ECs that
are normally exposed to much lower VEGF concentrations
(Fig. 3a, b and Supplementary Fig. 5a). Notch thus appears to
suppress endothelial MAPK/ERK activity in both proliferative
and quiescent ECs. This Notch-inhibition-induced increase in P-
ERK levels is consistent with the observed cell-cycle re-entry of
mature ECs, but not with the cell-cycle exit of angiogenic ECs
observed in the retina. We therefore hypothesised that high
mitogenic signalling (P-ERK) at the AF, caused by Notch inhi-
bition in a context of extant high VEGF signalling, could trigger
an autoregulatory cell-cycle exit. To test this hypothesis, we
crossed iMb-Vegfr2-Mosaic mice13 with Cdh5(PAC)-CreERT2
mice, allowing us to conditionally activate or inhibit Vegfr2 and
ERK signalling at single-cell resolution and in a mosaic fashion in
the embryo or in angiogenic retinal ECs (Fig. 3c–f). In these mice,
ECs expressing MbTomato express a constitutively active form of
VEGFR235, which significantly increases P-ERK activity (Fig. 3d
and Supplementary Fig. 5b); in contrast, cells expressing MbYFP
express a dominant-negative tyrosine kinase mutant VEGFR2
(VEGFR2TkMut), which impairs VEGFR2 signalling13. In iMb-
Vegfr2-Mosaic animals, the recombination is biased towards
the first MbTomato-VEGFR2Ac. cassette, since the LoxP2 and
LoxP3 sites are separated by a large genetic distance, resulting in
the lower frequency of MbYFP+ and MbKate2+ cells (Fig. 3c).
To assess the relative proliferation of these cells shortly after
genetic induction, we pulsed Cdh5-CreERT2+ ECs with tamox-
ifen at P3 and waited 3 days. Similarly to ECs lacking Notch
signalling, ECs with higher VEGFR2 activity and P-ERK levels
(Fig. 3d) exited the cell cycle (Fig. 3e–g). Most single ECs with
high (MbTomato+) or low (MbYFP+) VEGFR2 signalling did
not divide, and a smaller fraction completed the ongoing cell
cycle to form 2-cell clones (Fig. 3h, i). Consistent with these
observations, increasing VEGFR2 signalling in the developing
retinal vasculature resulted in a significant decrease in angio-
genesis (Fig. 3j, k). Thus, abnormally high mitogenic signals (P-
ERK), induced either by increased VEGF signalling or decreased
Notch signalling, arrest angiogenesis.
Our results could also suggest that the increase in P-ERK levels,
after Notch inhibition, might be dependent on a cell-autonomous
increase in Vegfr2 expression and signalling, as previously
suggested1,32,36,37. However, Vegfr2 expression is not altered in
ECs after Notch LOF in vivo (Supplementary Fig. 6a, b), and cells
expressing a dominant-negative tyrosine kinase mutant VEGFR2
(VEGFR2TkMut), which impairs VEGFR2 signalling and EC
proliferation, can reenter the cell cycle and expand in the absence
of Dll4/Notch signalling (Supplementary Fig. 6c, d), in agreement
with other previous findings13,19. These results suggest that VEGF
and Notch activities can both impact P-ERK levels and EC
proliferation, independently of each other. However, at the AF
both pathways are active, and therefore the overall effect on ERK
signalling and EC proliferation of one pathway depends on the
activity of the other.
Tip cell fate mapping shows their low-proliferative capacity.
Tip cell specification is thought to be induced by the combination
of high-VEGF and low-Notch signalling in a subset of ECs at the
AF11,18. This process is transient, not fixed, allowing the
reiterative sprouting and branching of other cells37. This implies
that, at any given moment, cells at the tip position may be out-
competed by adjacent cells that more strongly sense or respond to
VEGF or other stimuli. Tip cell position may therefore not
accurately reflect the cell’s activation status. To label with high
resolution only those ECs that received a high-VEGF signalling
input at the AF, and to fate-map their progeny, we generated Gt
(Esm1)tm1(HA-H2B-Cerulean-2A-iCreERT2) mice by CRISPR/Cas9-
assisted gene targeting in mouse ES cells (Supplementary Fig. 7a).
Unlike most genes expressed by angiogenic vessels, Esm1 is
strongly and exclusively expressed in endothelial tip cells38,
probably reflecting a high threshold for transcriptional activation.
As expected, at any given moment, only a subset of tip cells
experienced high-VEGF signalling and showed detectable HA-
H2B-Cerulean expression (Fig. 4a). Consistent with the results
presented in the previous section, only 31% of the Esm1+ tip cells
were cycling (Ki67+), contrasting sharply with adjacent angio-
genic stalk cells, which were 96% Ki67+ (31% Fig. 4a vs. 96%
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Fig. 3 Angiogenic ECs with high VEGFR2 and ERK signalling exit the cell cycle. a Confocal micrographs of the retinal angiogenic front in iChr-Cerulean/GFP x
Tie2-Cre reporter mice (see also Supplementary Fig. 4a), showing labelling of EC nuclei (Cerulean/GFP+). Activated ERK levels (P-ERK, red) are high in the
nuclei and cytoplasm of endothelial tip cells (left image). Dll4/Notch inhibition increases P-ERK levels, particularly in stalk cells. b Quantification of P-ERK
signals in tip and stalk cells from animals 24 h after injection with control IgG or anti-Dll4. Comparison of indicated parameters in large microscopic fields
of IgG control (n= 3) or anti-Dll4 (n= 4) treated mice. c iMb-Vegfr2 Mosaic construct with genetic distances in kilobases (kb). d ECs expressing VEGFR2Ac
(MbTomato+ , yellow arrows) have high P-ERK levels, like some endothelial tip cells (white arrowheads). See also Supplementary Fig. 5b. e–g ECs
expressing VEGFR2Ac (MbTomato+) or VEGFR2TKMut (MbYFP+) exit the cell cycle. Only a small fraction of MbTomato+ or MbYFP+ ECs are in S-phase
(Erg+/EdU+-white nuclei), indicated with white arrowheads. Chart shows quantification of several microscopic fields from retinas of different mice (n=
5). h, iMost single ECs with very high (MbTomato+) or low (MbYFP+) VEGFR2 signalling do not divide over a 3 day period. The iChr-Control-Mosaic allele
was used to increase single-cell pulse–chase clonal resolution. Chart shows quantification of several clones in large microscopic fields (n= 4 retinas per
group). j, k The increase in VEGFR2 activity in iMb-Vegfr2-Mosaic Cdh5-CreERT2 retinal vessels from P2 to P6 arrests physiological angiogenesis.
MbTomato labelling shows the mosaic induction of the transgene in the endothelium (isolectinB4+), resulting in a significant decrease in vascular
development. Chart shows quantification of large microscopic fields from several retinas of control (n= 3) and mutant (n= 2) mice. Scale bars in all
panels, 100 μm. Error bars indicate std. dev.; NS nonsignificant; ***p < 0.0005; **p < 0.005. One-way ANOVA with Tukey’s post hoc test (b, g) or two-
tailed unpaired t test (k). Source data are provided as a Source Data file
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Supplementary Fig. 4f—IgG 24 h bar). Dll4/Notch signalling
blockade induced a marked increase in the number of Esm1-
expressing stalk cells (Fig. 4b), similar to our findings with P-ERK
(Fig. 3a). Thus, while VEGF induces high P-ERK and Esm1 levels
in tip cells, in stalk cells this induction is suppressed by the
higher Notch activity in these cells.
To genetically pulse-label single endothelial tip cells and track
their proliferative dynamics, we crossed Esm1-HA-H2B-Cerulean-
2A-iCreERT2 and Rosa26-LSL-TdTomato39 reporter mice (Fig. 4c)
and induced recombination with tamoxifen at P3. This resulted in
very few recombined clones per retina arising from a few Esm1+
tip cells (Fig. 4c left and Supplementary Fig. 7b), enabling us
to score and assign single-tip-cell-derived clones over a 4-day
period. To pulse single-endothelial stalk cells at very high-clonal
resolution, we crossed iMb-Control Mosaic and iChr-Control
Mosaic mice with Cdh5(PAC)-CreERT2 mice (Fig. 4d and
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Supplementary Fig. 7c). Individual Esm1+ tip cells produced on
average fewer progeny than individual stalk cells. In most cases,
the Esm1+ tip cell pulse generated 2-cell clones after 4 days
(Fig. 4c, blue bars), whereas a Cdh5+ stalk-cell pulse tended to
generate 4-cell clones after only 3 days (Fig. 4d). This shows that
even though tip cells are exposed to more VEGF, on average they
proliferate significantly less, presumably because they exit the cell
cycle or are arrested; in contrast, the stalk cells proliferate and
form larger clones. Interestingly, when Dll4/Notch signalling was
blocked, Esm1+ tip cells proliferated even less and most clones
were formed by only 1 cell, instead of 2 cells (Fig. 4c). This result
is consistent with a model where during the 4 days of the
pulse–chase genetic experiment, non-proliferative tip cells can
become proliferative stalk cells, but Dll4/Notch blockade inhibits
this phenotypic switch, preventing these initially Esm1+/KI67−
tip cells from reentering the cell cycle and adopting a clonal
expansion mode typical of stalk cells.
Taken together, our results suggest that the Notch signalling
effect on the endothelium is highly context dependent and is an
essential element in maintaining a mitogenic balance that
oscillates between sustained vascular proliferation in stalk cells
and cell-cycle exit in sprouting tip cells. Notch blockade in
VEGF-activated, high P-ERK, Esm1+ tip ECs further blocks their
expansion, presumably by preventing tip-to-stalk cell transition.
In contrast, blocking Dll4/Notch in proliferating (Ki67+, Esm1−)
retinal stalk cells, which have relatively low-P-ERK levels, leads to
an initial acceleration of the cell cycle and proliferation, but after
48 h these cells also exit the cell cycle (Fig. 2d and Supplementary
Fig. 4d), a characteristic of sprouting tip cells. In mature quiescent
retinal ECs (Ki67−), Dll4/Notch blockade induces a milder
increase in P-ERK levels (compare Supplementary Fig. 5a chart
with Fig. 3b chart), which is productive and sufficient to induce
cell-cycle entry (mature area in Fig. 2b, d and h).
p21 is abundant in tip cells and regulated by VEGF/Notch. The
data shown above suggest that during normal vascular develop-
ment high-ERK activity is achieved only in the presence of high-
VEGF and low-Notch signalling, a characteristic of tip cells
(Fig. 3a left). To determine the molecular profile of angiogenic
ECs with different Notch and VEGF signalling levels, we profiled
gene expression in FACS-sorted AF retinal ECs from animals
injected with control IgG, anti-Dll4 or anti-VEGF. Inhibition of
Dll4/Notch signalling significantly increased expression at the AF
of genes enriched in tip cells (Esm1, Angpt2, Apln) and the cell-
cycle inhibitor Cdkn1a (p21), whereas inhibition of VEGF sig-
nalling had the opposite effect (Supplementary Fig. 6a, b). Our
data above show that VEGF high/Esm1+ endothelial tip cells exit
the cell cycle more frequently than stalk cells (69% of tip cells are
KI67− in Fig. 4a vs. 4% stalk cells KI67− in Supplementary
Fig. 4f). We also found that a very high p21 protein content was
more frequent in tip cells, particularly Esm1+ tip cells (Fig. 4e top
panel and f), which are the cells with the highest P-ERK levels
(Fig. 3a left). To confirm the direct link between VEGF/ERK
signalling and p21, we analysed p21 expression in iMb-Vegfr2-
Mosaic vessels, in which P-ERK is elevated in all MbTomato-2A-
Vegfr2Ac.+ cells (Fig. 3d and Supplementary Fig. 5b). Cells with
very high-VEGFR2/ERK signalling strongly upregulated p21
(Fig. 4e, g) and exited the cell cycle (Fig. 3e–g). Similarly, after
Dll4/Notch inhibition for just 24 h, p21 protein levels increased
significantly in stalk ECs (Fig. 4h–j), again suggesting that these
stalk ECs adopt a tip-like phenotype in the absence of Notch
signals and activate the expression not only of tip cell markers
(Esm1, Angpt2, Apln), but also of a cell-cycle inhibitor that is
normally highly expressed only by sprouting tip cells. Previous
studies with EC lines suggested that p21 might positively regulate
EC proliferation40,41. We detected elevated p21 in KI67+ and P-
ERK− high stalk ECs 24 h after Dll4/Notch inhibition (compare
Fig. 4i with Supplementary Fig. 4b, f); however, at 48 h (Fig. 2d
and Supplementary Fig. 4d, f), most of the cells that were pre-
viously cycling (Ki67+) and p21+, had exited the cell cycle. This
finding indicates that the p21 upregulation observed after the
inhibition of Dll4/Notch signalling precedes cell-cycle exit, con-
sistent with its role as a cell-cycle inhibitor.
Single ECs with Notch LOF often upregulate p21 and sprout.
Similar to the effect of Dll4/Notch signalling inhibition for 24 h,
sustained Rbpj deletion in angiogenic retinal ECs from P1 to P6
also resulted in strong increases in P-ERK and p21, coinciding
with a marked arrest of EC proliferation and angiogenesis, even
though this was accompanied by increased vascular density and
hypersprouting (Fig. 5a–d).
By inducing single-cell mutant mosaics in Cdh5-CreERT2 ×
iSuRe-Cre × Rbpjfloxed or iChr-Notch Mosaic mice, we determined
that the p21 upregulation and cell-cycle exit after Rbpj/Notch
signalling loss is cell-autonomous, increasing in frequency with
the proximity to the VEGF source. Rbpj deletion, or expression of
DN-Maml1, upregulated p21 in individual ECs at the AF,
particularly at the leading edge, but not in the more mature
vascular area (Fig. 5e–h and Supplementary Fig. 8a–d). In
addition, single ECs with Rbpj/Notch signalling loss and higher
p21 expression were found more frequently at the leading edge of
the vascular network (Fig. 5h and Supplementary Fig. 8e),
suggesting that p21+ and arrested (KI67−) ECs have higher
migratory activity and occupy the tip position more frequently
than the adjacent proliferative (KI67+/p21−) cells.
Fig. 4 Tip cells with endogenous high VEGF activity proliferate less than stalk cells. a Confocal micrographs showing that the Esm1-HA-H2B-Cerulean-2A-
iCreERT2 allele is expressed by a subset of endothelial tip cells in growing retinal vessels at P6. Only 31% of these cells are cycling (KI67+), contrasting
with the adjacent endothelial stalk cells (96% cycling, see Supplementary Fig. 4b and f). b Inhibition of Dll4/Notch signalling upregulates the expression
of Esm1-HA-H2B-Cerulean in ECs (Erg+) at the angiogenic front. Chart shows quantification of several microscopic fields from control (n= 3) and mutant
(n= 3) mice. c In mice containing the Esm1-HA-H2B-Cerulean-2A-CreERT2 and Rosa26-LSL-TdTomato alleles, the very low-recombination frequency allows
individual endothelial tip cells to be genetically pulse–chased and their progeny followed over a few days. Blockade of Dll4/Notch signalling with Anti-Dll4
decreased the proliferation or clonal expansion of Esm1+ tip cells. The line above the bar indicates the most frequent clone size. Number of clones
quantified is indicated. Please see also Supplementary Fig. 7b. d High-resolution Dual ifgMosaic labelling (iMb2-Mosaic × iChr2-Mosaic) and clonal analysis of
single Cdh5-CreERT2+ stalk cells (see also ref. 13). Recombination was induced with tamoxifen at P3 and vessels were analysed at P6. The histogram
shows the frequency of identified dual-labelled cell clones according to their size. Total number of clones quantified is indicated. The line above the bar
indicates the most frequent stalk-cell dual-labelled clone size (four cells). Please see also Supplementary Fig. 7c. e–g Confocal micrographs showing
p21 protein in sprouting tip cells and very few stalk cells during normal retinal angiogenesis. ECs with high-VEGFR2 signalling (MbTomato+) strongly
upregulate p21. Charts show quantification of several large microscopic fields from 4 (f) or 2 (g) full retinas per group. h–j Dll4/Notch signalling blockade
for 24 h induces a strong increase in the frequency of p21-expressing ECs (n= 3 mice per group). Scale bars in all panels, 50 μm. Error bars indicate std.
dev.; ***p < 0.0005; **p < 0.005. Two-tailed unpaired t test. Source data are provided as a Source Data file
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Fig. 5 Individual ECs with loss of Rbpj/Notch signalling often express p21 and occupy the leading edge. a–d The induction of Rbpj genetic deletion from P1
to P3 results in a strong increase of p21 and P-ERK levels at the AF in P6 retinas. Charts show quantification of several large microscopic fields (n= 3 mice
per group). Scale bars, 200 μm. e Confocal micrographs of P6 retinas from animals with inducible mosaic deletion of Rbpj in ECs (RbpjiECMosaic-KO)
expressing MbTomato-2A-Cre. Images to the right are high-magnification views of boxed areas, showing the indicated signals in more detail. Scale bar, 115
μm. f, g Quantification of mutant (Tomato+) and control (Tomato−) ECs (ERG+) from RbpjiECMosaic-KO retinas (n= 6). Individual cells without Rbpj/
Notch signalling (MbTomato-2A-Cre+) are more frequently p21+, especially if they are at the leading edge of retina vessels. In the mature vascular area,
most ECs with Rbpj deletion do not upregulate p21. Note that a fraction of Tomato− cells may have Rbpj deletion (compare white bars in f with g). h Cells
without Rbpj/Notch signalling (MbTomato-2A-Cre+), are more frequently found at the leading edge of vessels than at the angiogenic front. Error bars
indicate std. dev; ***p < 0.0005. Two-tailed unpaired t test. Source data are provided as a Source Data file
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These results suggest the existence of a cell-intrinsic auto-
regulatory mechanism, regulated by physiological Notch levels,
that maintains endothelial stalk cell identity and proliferation by
repressing overactivation of ERK, and thus the expression of the
cell cycle inhibitor p21, both of which are upregulated in actively
sprouting tip cells. Interestingly, only a fraction of single-
angiogenic ECs with full Dll4/Notch or Rbpj LOF had high p21
levels at any given timepoint of analysis (Fig. 4i, j Anti-Dll4 (24 h)
and Fig. 5f Rbpj deletion (P1–P6)), suggesting single-cell
heterogeneity in p21 upregulation. This heterogeneity, may be
related with the known heterogenous and highly dynamic
response of ECs to VEGF signalling37, and is also evident in
the Esm1 reporter and P-ERK immunostaining analysis presented
above (Fig. 4a, b and Fig. 5b).
ERK regulates p21 to balance EC sprouting and proliferation.
Our results show that EC p21 expression in vivo coincides with
increased P-ERK, which can be induced either by high VEGF
signalling or by Notch signalling inhibition in the context of
active angiogenesis; moreover, soon after upregulating P-ERK
and p21, most of these ECs exit the cell-cycle. Weak ERK acti-
vation is associated with an increase in mitogen-induced cell
proliferation42; however, strong ERK activation was previously
linked with cell-cycle arrest and p21 upregulation in established
cell lines in vitro43,44. In agreement with this, P-ERK levels are
low in proliferating endothelial stalk cells, and high in sprouting
tip cells. To determine the functional link between ERK activity,
p21, and EC proliferation we examined the effect of the MEK/
ERK inhibitor (SL327) during retinal angiogenesis. Similarly to
previous results obtained in zebrafish embryos33, ERK activity
inhibition for 24 h prevented EC sprouting; moreover, it also
significantly diminished the frequency of angiogenic and mature
ECs in S-phase, particularly after anti-Dll4 treatment (Fig. 6a–e).
ERK activity inhibition for 24 h also significantly reduced p21
upregulation in anti-Dll4 treated retinas, although p21 protein
remained in some endothelial tip cells (Fig. 6f, g), suggesting slow
p21 protein turnover. These results indicate that while strong
ERK activation as occurs in tip-ECs induces p21 expression and
sprouting, the weaker ERK activity in stalk-ECs is unable to
induce p21 expression, and instead sustains EC proliferation.
p21 specifically arrests ECs with high mitogenic stimulation.
Given the strong regulation of p21 by VEGF, Notch and ERK
stimuli, we next investigated the role of p21 in angiogenesis.
Interestingly, animals with full p21 LOF displayed no significant
defects in retinal angiogenesis or in the frequency of proliferation
by stalk-ECs with physiological Notch signalling (Fig. 7a, c, d),
likely because p21 expression is undetectable in most of these cells
(Fig. 7e, f). In contrast to stalk cells, 70% of Esm1-Cerulean+
endothelial tip cells were p21+ (Fig. 7e, f) and KI67− (Fig. 4a).
In the absence of p21 function, the frequency of arrested Esm1-
Cerulean+ endothelial tip cells decreased to 40%, whereas the
frequency of cycling stalk-cells remained the same (Fig. 7g, h).
These results indicate that p21 inhibits the proliferation of tip
cells but not stalk cells, presumably because it is mainly expressed
by VEGF-high, or Notch-low, Esm1+ tip cells. When Dll4/Notch
signalling was inhibited in retinal vessels, p21 expression
increased significantly in stalk cells (Fig. 4i). In this context of
p21 upregulation, we observed that p21 loss partially inhibited the
cell-cycle arrest observed after Dll4/Notch blockade (Fig. 7b, c),
leading to a greater increase in EC number and density (Fig. 7d).
These results indicate that the p21 upregulation observed in tip
cells, or after Dll4/Notch blockade (Fig. 4h–j), is one of the drivers
of cell-cycle arrest of these cells, even though other cell-cycle
regulators and checkpoints may partially compensate the full loss
of p21 function.
Discussion
Pharmacological compounds that inhibit or promote the function
of the VEGF and Notch pathways have been widely used in the
clinics. The currently prevailing view is that high VEGF signalling
or Dll4/Notch blockade increases angiogenesis and EC pro-
liferation in any physiological or pathological context1,8,45,46. Our
study shows that the effects of VEGF, Notch, and ERK signalling
are instead highly context-dependent. In the case of angiogenic
and already activated ECs, the increase in EC proliferation
observed after increasing VEGF or decreasing Dll4/Notch sig-
nalling is transient, and is followed by cell-cycle exit. Our study
may also explain the failure of VEGF-delivery therapies to pro-
mote functional angiogenesis, for example those used to treat
cardiovascular ischaemic disease47. According to our results,
delivering additional VEGF will induce p21 and cell-cycle arrest
in vessels close to the VEGF source while presumably increasing
the activation of more distal vascular cells, which are the least
important for effective vascularisation and irrigation of the
ischaemic tissue.
In this study, we used a series of in vivo pulse–chase genetic
and pharmacological experiments that provide a detailed analysis
of the functional interactions between VEGF, Notch, ERK, and
p21 in angiogenic and quiescent vessels. We show how these
molecules act in different vascular contexts and how their levels
need to be properly balanced in order to regulate EC proliferation
and prevent premature cell-cycle arrest. Our results suggest that
ECs have a bell-shaped dose-response to mitogenic stimuli
(Fig. 8a), according to which a high-VEGF input, or low-Notch
input, induces ERK phosphorylation and downstream signalling,
which when high induces p21 and cell-cycle arrest, a process
associated with effective endothelial sprouting and migration.
Most sprouting retinal tip cells are Ki67−/Esm1+/p21+ and have
high P-ERK levels (Fig. 8b). The induction of these molecular
mechanisms by VEGF, is strongly counteracted by higher Notch
activity in stalk cells. Therefore, the main role of physiological
Notch levels at the AF is to supress ERK signalling, in order to
maintain stalk-cell proliferation and prevent their premature
arrest (Fig. 8c). The cell-cycle arrest induced by Notch inhibiton
in proliferating stalk cells is dependent on the increase in ERK
activity and p21 levels. In contrast to angiogenic vessels, mature
and quiescent ECs have significantly lower VEGF and ERK sig-
nalling levels, and therefore the increase in ERK activity after
Notch inhibition is more moderate and therefore productive,
inducing cell-cycle entry (Fig. 8c).
Recent work suggested that some tip cells or tip-derived ECs
may have high Notch and Cxcr4 signalling, which was found to
be required for their migration toward arteries48,49. Our results
suggest that most retina tip cells, particularly those with the
highest VEGF signalling (Esm1-Cerulean+/p21+), have low-
Notch signalling and migrate in the opposite direction. We also
show that conversion of tip cells to proliferative stalk cells can be
prevented by blocking Dll4/Notch activation, maintaining their
excessive ERK and p21 expression and thus preventing the
adoption of a more proliferative stalk cell phenotype. It is
nonetheless possible that a fraction of tip cells has high Notch
activity, or acquires it during the dynamic phenotypic inter-
conversion of tip cells to stalk cells. This may induce reversal of
EC polarity and the migration of tip cells away from the angio-
genic front and towards the arteries, as proposed recently48–50.
Contrasting our in vivo data, Notch signalling inhibition, or
increased VEGF signalling in EC lines always increases their
proliferation (Supplementary Fig. 1)21,22, suggesting that the bell-
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09875-7
10 NATURE COMMUNICATIONS | (2019)10:2016 | https://doi.org/10.1038/s41467-019-09875-7 | www.nature.com/naturecommunications
shaped dose–response and cell-cycle arrest mechanism we iden-
tified here is inactive in vitro, or is bypassed. This discrepancy
may reflect significant differences between the in vitro and in vivo
biochemical and physical endothelial microenvironment, such as
shear stress, oxygen concentration, EC-to-EC junctional stability
and nutrient availability. All these factors might interact with
and modify the operation of the cell-cycle arrest mechanism
identified.
The role of Cdkn1a (p21) in angiogenesis and its regulation by
Notch has mostly been studied in vitro. Notch activation in EC
lines suppresses p21 expression, and since Notch overactivation is
accompanied by cell-cycle arrest, p21 was proposed to be a
positive regulator of EC proliferation40. This contrasts with the
proposed interaction between Notch and p21 in keratinocytes,
where Notch activation induces p21 expression to induce cell-
cycle arrest51. Our results show that p21 plays a minor role
during physiological angiogenesis, likely because under physio-
logical Notch signalling, it is expressed only by endothelial tip
cells, which constitute a very small fraction of the proliferating
EC pool. However, when Notch signalling is inhibited, p21
expression and its importance for angiogenesis increase.
The expression of p21 was shown before to be triggered by
many different pathways, including DNA-damage and p53,
labelling cells undergoing senescence52. However, p53 expression
did not change after Dll4/Notch inhibition (Supplementary
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Fig. 6 Inhibition of ERK phosphorylation decreases EC sprouting and proliferation. a, b Confocal micrographs of retinas treated with IgG (control) or anti-
Dll4 antibody in the presence or absence of MEK/ERK inhibitor (SL327) for 24 h. P-ERK immunostaining is strongly reduced in SL327-treated retinas,
leading to decreased sprouting (n= 3 mice/6 retinas per group). c Confocal micrographs of retinas treated with IgG (control) or anti-Dll4 antibody in the
presence or absence of SL327 for 24 h and immunostained for ERG (red) and EdU (blue) to check effect of ERK signalling on EC proliferation. Dual ERG
+/EdU+ cells are pseudocolored in green. d, e Inhibition of ERK phosphorylation with SL327 for 24 h, significantly reduces the frequency of EdU+/ERG+
ECs at the AF and the anti-Dll4 induced proliferation in the mature vascular area (n= 3 mice/6 retinas per group). f, g Confocal micrographs of retinas
treated with IgG (control) or anti-Dll4 antibody in the presence or absence of SL327 for 24 h and immunostained for ERG (red) and p21 (green).
Quantifications show that SL327 treatment for 24 h reduced the frequency of p21+ ECs, with a particularly strong inibitory effect on the p21 upregulation
induced by anti-Dll4 (n= 3 mice/6 retinas per group). Scale bars in all panels, 200 μm. Error bars represent StDev. *p < 0,05, ***p < 0.0005 and NS not
significant. One-way ANOVA with Tukey’s post hoc test. Source data are provided as a Source Data file
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contribution of p53 and DNA damage for the observed upregu-
lation of p21, our work shows that p21 expression can be instead
directly activated by ERK signalling in ECs (Fig. 6), similarly to
what was shown before in other cell types53,54.
Here, we have used mainly the embryonic and postnatal retinal
angiogenesis systems as experimental models because they permit
a high level of genetic, cellular and temporal resolution. Given the
context and dose-dependent signalling roles identified in this
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study, it is possible that an increase in VEGF, or decrease in
Notch signalling, will trigger different outcomes in different
vascular networks or pathological settings. Indeed, and in con-
trast to the Esm1+ retinal tip cells, which need to migrate very
actively on a layer of hypoxic astrocytes, zebrafish intersegmental
tip cells seem to be able to sprout and proliferate at the same
time4, presumably due to relatively lower-VEGF signalling or
higher Notch signalling. We propose that this heterogeneity in
the behaviour of tip, stalk and quiescent ECs, is induced by a bell-
shaped dose–response to mitogenic/ERK stimuli that is highly
dependent on the vascular and signalling context and oscillates
between active endothelial proliferation and cell-cycle arrest
(Fig. 8).
This study shows how critical the cellular context and the levels
of mitogenic stimuli are for appropriate angiogenesis, where more
can result in less. The identified dual, and often mutually exclu-
sive, role of mitogenic stimuli levels on endothelial sprouting and
proliferation will need to be considered in future pro-angiogenic
and anti-angiogenic therapies.
Methods
Mice, genetic experiments and pharmacological inhibition. To generate Notch
and VEGFR endothelial-cell mosaics, we intercrossed the endothelial-specific Cre
lines Tie2-Cre29 or the tamoxifen inducible Cdh5(PAC)-CreERT2mouse line25 with
the following ifgMosaic mouse lines:13 iChr-Notch-Mosaic (Gt(Rosa)26Sortm1(iChr-
Notch Mosaic)), iChr-Notch-V2-Mosaic (Tg(BAC Rosa26)(iChr-Notch Mosaic-v2)) or iMb-
Vegfr2-Mosaic (Tg(BAC Rosa26)(iMb-Vegfr2 Mosaic)). To specifically label the nuclei of
ECs in some experiments, we used the iChr-Cerulean/Gfp Mosaic (Gt(Rosa)
26Sortm1(iChr-Cerulean/GFP/Kate2 Mosaic) mouse line (Supplementary Fig. 2i–o). To
increase the mosaic single-cell clonal resolution after recombination, we inter-
crossed the iMb2-Control-Mosaic (Gt(Rosa)26Sortm1(iMb2-Control-Mosaic)) and iChr2-
Control-Mosaic (Gt(Rosa)26Sortm1(iChr2-Control-Mosaic)) mouse lines13.
To recombine and fate-map endothelial tip cells experiencing high VEGF
signalling, we generated the Esm1tm(HA-H2B-Cerulean-2A-iCreERT2) mouse line. By
using CRISPR/Cas9-assisted homologous-dependent recombination in mouse ES
cells, we inserted the HA-H2B-Cerulean-2A-iCreERT2 cassette in-frame with the
endogenous Esm1 gene ATG initiation codon (Supplementary Fig. 5a). These gene-
targeted ES cells were validated by Southern blot and later used to produce mice.
This mouse line was later intercrossed with the Gt(Rosa)26Sortm14(CAG-LSL-tdTomato)
Hze39 reporter mouse line (abbreviated as Rosa26-LSL-TdTomato) to fate-map
individual endothelial tip cells.
For experiments involving inducible and endothelial-cell specific genetic Notch
signalling loss-of-function we used Dll4floxed mice55 or Rbpjfloxed mice24 crossed
with the Cdh5(PAC)-CreERT225 or iSuRe-Cre mouse lines (detailed description of
this line will be provided elsewhere). All primer sequences required to genotype
mice are provided in Supplementary Table 1.
To activate CreERT2 in pups, we administered 120 µg/g body weight of
tamoxifen (T5648) or 20 µg/g of 4-OH tamoxifen (H6278) diluted in a
1:1:2 solution of EtOH:Cremophor:phosphate buffered saline (PBS)56. To
investigate the function of p21 in angiogenesis, we used Cdkn1a (p21) knockout
mice57. Dll4/Notch signalling inhibition in ECs was achieved by using the
humanised phage antibody YW152F, developed by Genentech5. Human IgG
(Sigma, I4506) was used in littermates as a control treatment. A single
subcutaneous injection of 40 µl of IgG or anti-Dll4 (0.5 mg/ml in PBS) was
administered at the indicated stage. Retinas were collected 12, 24, 48 or 72 h after
blocking antibody administration and processed for immunohistochemistry. In
some experiments, the Y-secretase inhibitor IX (DAPT, Calbiochem) was injected
intraperitoneally (IP) at 100 mg/kg per day. To inhibit Notch signalling and ERK
phosphorylation at postnatal stages anti-Dll4 (10 mg/kg) and SL327 (MEK
inhibitor from Selleckchem, at 120 mg/kg) were injected IP into mouse pups at P5
and again 16 h later, before collecting the tissues at P6 (injections at −24 and −8 h
time points). To detect proliferating cells actively synthesising DNA, EdU
(Invitrogen—A10044) was injected IP 4 h before sacrifice; the signal was developed
with the Click-it EdU Alexa Fluor 647 Imaging Kit.
Experiments involving animals were conducted in accordance with institutional
guidelines and laws, following protocols approved by local animal ethics
committees and authorities (Comunidad Autónoma de Madrid and Universidad
Autónoma de Madrid—CAM-PROEX 177/14 and CAM-PROEX 167/17).
Immunohistochemistry. For mouse retina immunostaining, eyes were collected at
the indicated time points and fixed in 4% PFA in PBS for 1 h at room temperature
(RT). After two PBS washes, retinas were micro-dissected and stained as described
previously18 . Briefly, retinas were blocked and permeabilized with 0.3% Triton X-
100, 3% foetal bovine serum (FBS) and 3% donkey serum in PBS. Samples were
then washed twice in PBLEC buffer (1 mM CaCl2, 1 mM MgCl2, 1 mM MnCl2 and
1% Triton X-100 in PBS). Biotinylated isolectinB4 (Vector Labs, B-1205, diluted
1:50) or primary antibodies (see below) were diluted in PBLEC buffer and tissues
were incubated in this solution for 2 h at RT or overnight at 4 °C. After five washes
in blocking solution diluted 1:2, samples were incubated for 1 h at RT with Alexa-
conjugated secondary antibodies (Molecular Probes). After two washes in PBS,
retinas were mounted with Fluoromount-G (SouthernBiotech). To detect EdU-
labelled DNA, an additional step was performed before mounting using the Click-
It EdU kit (Thermo Fisher, C10340).
Primary antibodies were used against the following proteins: Erg (Abcam,
ab110639 1:500); GFP/YFP/Cerulean (Acris, R1091P, 1:400); p21(Santa Cruz,
sc-397-G, 1:100 and rat anti-p21 from CNIO-Centro Nacional de Investigaciones
Oncológicas); Ki67 (Thermo Fisher, RM-9106-S0, 1:400); Cherry/Tomato
(Clonetech, 632496, 1:400); pERK (Cell signalling, 4370S, 1:400). To combine
multiple antibodies in the same immunodetection, in some instances the
following proteins were detected with conjugated primary antibodies: GFP/YFP/
Cerulean (AF-488, Invitrogen A213111, 1:100); Erg (AF-647, Abcam ab196149,
1:100); HA (AF-647, Cell Signalling 3444S, 1:100 or AF-594, Thermo Fisher A-
21288 1:200); Tomato (CF-594, Biotium 20422, 1:400); and V5 (FITC, Thermo
Fisher R963–25 1:100 or AF-488, Biorad MCA1360A488, 1:100). To detect two
primary antibodies from the same host, we combined detection with conjugated
Fab fragment secondary antibodies and directly conjugated primary antibodies.
The following secondary antibodies were used: donkey anti-rabbit (Thermo
Fisher, AF-488, A-21206 or AF-680, A-10043); donkey anti-goat (Thermo
Fisher, AF-488, A-11055 or AF-633, A21082 or AF-647, A-21447 or AF-680,
A-21447); donkey anti-rabbit Fab fragment (Jackson Immunoresearch, Cy3,
711-167-003 or AF-647 711-607-003); and streptavidin 405 (Thermo Fisher,
S-32351, 1:200).
Flow cytometry of ECs. To detect, separate, and profile the different endothelial
cell populations in ifgMosaic or iSuRe-Cre mice, we interbred these mice with Tie2-
Cre or Cdh5-CreERT2 animals to activate recombination and fluorescent protein
expression in the endothelium. Embryos or organs were collected in PBS,
minced, and digested with 2.5 mg/ml type I collagenase (Thermo Fisher,
17100017), 2.5 mg/ml dispase II (Thermo Fisher, 17105041), and 50 ng/ml DNAseI
(Roche) at 37 °C for 20 min to create a homogeneous cell suspension. Cell sus-
pensions were passed through a 70 μm filter to remove any undigested tissue. To
remove erythroid cells, cell suspensions and blood samples were incubated for 10
min on ice in blood lysis buffer (0.15 M NH4Cl, 0.01M KHCO3 and 0.01M EDTA
in ddH20). Before analysis, cell suspensions were incubated at 4 °C for 30 min with
APC rat anti-mouse CD31 (BD Pharmigen) diluted 1:200. The Flow cytometry
analyses were performed either with a FACS Aria Cell Sorter (BD Biosciences) or a
Synergy4L Sorter. Viable (DAPI-) ECs (APC-CD31+) were sorted and analysed
according to their endogenous fluorescence (GFP, Cherry, Cerulean or
MbTomato).
To isolate ECs specifically from the neonatal mouse retina AF, we first separated
the mature and angiogenic-front vascular areas under a dissecting microscope.
Tissues from these two distinct areas were then cut and processed for dissociation
Fig. 7 p21 inhibits proliferation of ECs exposed to high-mitogenic stimulation. a–d ECs (ERG+ nuclei) in control and p21 knockout retinas (a) have similar
frequencies of cells in S-phase (Erg+/EdU+ double-positive cells, pseudocoloured green). After administration of anti-Dll4 antibody for 48 h (b), the
frequency of S-phase ECs decreased significantly in control retinas due to cell-cycle arrest. In p21 knockout retinas, anti-Dll4-induced cell-cycle arrest was
less frequent (c), and resulting in the generation of more ECs (d). Charts show quantification of large microscopic fields from several control and mutant
retinas (IgG 48 h, n= 4; p21KO IgG 48 h, n= 4; a-Dll4 48 h, n= 5; p21KO a-Dll4 48 h, n= 6). e, f Confocal micrographs of retinas from P6 Esm1-HA-H2B-
Cerulean-2A-iCreERT2 mice (n= 4) and corresponding chart (f), showing that 70% of Esm1+ tip-ECs (HA+, red) are p21+ (green), as indicated by the
yellow arrowheads. g, h Confocal micrographs of P6 retinas from control (n= 4) and p21KO (n= 4) mice carrying the Esm1-HA-H2B-Cerulean-2A-iCreERT2
allele, showing that p21 blocks tip-EC proliferation (yellow arrowheads indicate Ki67+, Esm1+ tip-ECs) but does not affect stalk-EC proliferation. Scale bars
in all panels, 50 μm. Error bars represent SEM (c, d) or std. dev. (f, h). NS nonsignificant; *p < 0,05; **p < 0.005. One-way ANOVA with Tukey’s post hoc
test (c, d), two-tailed unpaired t test (f, h). Source data are provided as a Source Data file
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with the Neural Tissue Dissociation Kit (Mylteny 130-092-628). The resulting
cell suspension was incubated with conjugated APC-anti-CD31 antibody (BD
Pharmingen, 551262), followed by DAPI staining to exclude dead cells. Viable
(DAPI−) ECs (APC-CD31+) were FACS sorted and processed for total RNA
extraction with the RNAeasy Micro kit (Qiagen). Between 300 and 2500 ECs were
collected per sample.
RNA isolation and qRT-PCR. A number of strategies were used to profile gene
expression in retinal ECs subjected to different Notch and VEGF signalling
modulations in vivo. Firstly, we treated neonatal mouse pups with control IgG or
with anti-Dll4 or anti-VEGF antibodies. Secondly, we treated P5 mice with vehicle
or DAPT for 24 h. Thirdly, we induced Rbpj deletion between P1 and P3 and
















































































































Fig. 8 High-mitogenic stimulation arrests angiogenesis. a Proposed bell-shaped dose–response to mitogenic stimulation regulated by Notch, VEGF, ERK,
and p21. At very low levels of VEGF signalling, ECs are quiescent, since they have Notch signalling, which supresses ERK activity and cell proliferation. Stalk
cells have a properly balanced level of Notch and VEGF signalling, resulting in an ERK activity level ideal for cell proliferation. Tip cells have
high-VEGF signalling, and low-Notch signalling, resulting in cumulative high ERK activity, which induces p21, cell-cycle arrest, and cell sprouting/migration.
b Illustration showing the identified distribution of the indicated cellular markers in tip, stalk and quiescent ECs. Colours indicate P-ERK (red cytoplasm),
Esm1/p21 (green nuclei), KI67 (blue if positive and dark grey if negative). Colour intensity indicates the observed strength of signal or expression. At the
angiogenic front, endothelial tip cells receive a higher mitogenic stimulus from VEGF. This induces ERK activation and high expression of Esm1 and p21.
Higher Notch signalling in stalk cells attenuates the VEGF-induced ERK and p21 activation. In the more mature and quiescent vascular areas, most ECs have
very low P-ERK levels and have already exited the cell cycle (KI67−) because they are exposed to less VEGF. However, these cells still have active Notch
signalling, which is important for maintaining their quiescence. c When Dll4/Notch signalling is inhibited, angiogenic stalk cells display a tip-cell like profile
and upregulate Esm1 expression and ERK phosphorylation. This leads to p21 expression, which induces the cell-cycle arrest of stalk-cells, and compromises
the subsequent proliferation and development of vessels toward the hypoxic tissue area. Impairment of Dll4/Notch signalling in more mature and
quiescent ECs (grey), produces a distinct effect; here, the increase in P-ERK after Dll4/Notch inhibition is more moderate and productive, and ECs enter the
cell cycle even when VEGF signalling is low
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two animals were processed independently. In total, 12 retinas (6 animals/3 sam-
ples per group) were dissected and 300–2500 CD31-APC+ ECs per sample (with
or without other fluorescent protein expression) were sorted for RNA extraction
using the RNAeasy Micro Kit.
For quantitative real time PCR (qRT-PCR), RNA extracted from the ECs
obtained as above was retrotranscribed with the High Capacity cDNA Reverse
Transcription Kit with RNase Inhibitor (Thermo fisher, 4368814). cDNA was
preamplified with Taqman PreAmp Master Mix containing a Taqman Assay-based
pre-amplification pool containing a mix of the following Taqman assays (Applied
Biosystems): Actb, Gapdh, Pecam1, Cdh5, Hey1, Hey2, EphrinB2, Rbpj, Dll4,
Angpt2, Esm1, Apln, Cdk2, Cdk4, Cdkn1a, Cdkn1b, Trp53, Vegfr2/Kdr, Vegfr1/Flt1,
and Vegfr3/Flt4. Preamplified cDNA was used in standard qRT-PCR with gene-
specific Taqman Assays (Thermo fisher) in a AB7900 thermocycler (Applied
Biosystems).
In vitro assessment of the role of Notch in EC proliferation. HUVECs (50.000
cells, Lonza) were plated in a 96-well plate precoated with 0.2% gelatin and cul-
tured for 2 days in Endothelial Cell Growth Medium (PromoCell C22010). For the
experiment, the medium was exchanged and supplemented with VEGFA at a final
concentration of 50 ng/mL plus 10 μM dibenzazepine (DBZ, YO-01027 Sell-
eckchem) or an equal volume of DMSO (vehicle only control); cells were incubated
for an additional 24 h. At 4 h before the end of the experiment (20 h timepoint),
EdU (8 μM) was added to the medium. Cells were then washed with PBS and fixed
with 4% PFA for 10 min at RT, permeabilized for 10 min with TBST (25 mM Tris
HCl pH 7.4, 150 mM NaCl, 0.5% Triton X-100), blocked with TBST containing 2%
BSA and 2% donkey serum and incubated at 4 °C overnight with rabbit anti-Ki67
(1:200, Thermo Fisher, RM-9106-S0). The following day, cells were washed three
times with TBST, incubated with Cy3-conjugated donkey anti-rabbit and Hoechst
for 2 h at RT, washed twice with TBST, stained for EdU using the Click-iT EdU
Alexa Fluor 647 kit, washed twice with PBS, and mounted in Fluoromount. Images
were taken in a Zeiss LSM 700 confocal microscope.
To generate mouse ECs expressing the FUCCI reporter58, we first generated G4
mouse embryonic stem (ES) cells with CRISPR/Cas9-assisted knock-in of the
FUCCI construct in the Rosa26 locus, using a recently established method13. These
ES cells were later used to generate embryoid bodies (EBs) following published
protocols13. EBs were collected and deposited on an OP9 cell monolayer (a stromal
cell line from mouse bone marrow —ATCC CRL-2749) and cultured for 5 days in
OP9 cell medium (alfa-MEM+ 20% FBS). OP9 medium was changed every 2 days.
To enhance endothelial differentiation, the OP9 medium was supplemented with
human VEGF-A (Peprotech) at a final concentration of 30 ng/µl. At day 5, the
Notch inhibitor DBZ was added to the medium at a concentration of 10uM, 24 h
before the FACs sorting analysis. To analyse Venus fluorescence in the endothelial
population by FACS, cells were trypsinised for 20 min and resuspended for 30 min
in blocking buffer (DPBS+ 5% liophilized FBS). Cells were then respun and
resuspended for 30 min at 4 °C in the same buffer containing rat anti-ICAM2
(#553325, BD Biosciences), followed by incubation for 15 min at 4 °C with Donkey
anti-rat Alexa 647 conjugated antibody (Jackson laboratories, 1:200). Finally, cells
were washed with blocking buffer to eliminate unbound antibody, and the antibody
and Venus fluorescenct signals were taken analysed by flow cytometry.
Microscopy. We used different laser-scanning confocal microscopes depending on
the complexity of the immunostainings and the combination of fluorescent pro-
teins detected. For multicolour detection of up to 7 signals, we used the inverted
Leica TCS SP5 confocal (405, 488, 514, 546, 594 and 633 nm) or the Leica TCS SP8
confocal with a 405 nm laser and a white laser that allows excitation at any
wavelength from 470 to 670 nm. Confocal ZEISS LSM780 was also used spor-
adically. For the mouse retina analysis, we always used laser scanning confocal
analysis with a 10×, 20×, or 40× lens. We acquired individual fields or tiles of large
areas. All images shown are representative of the results obtained for each group
and experiment. Littermates were dissected and processed under exactly the same
conditions. Comparisons of phenotypes or signal intensity were made with pictures
obtained using the same laser excitation and confocal scanner detection settings.
Images were processed using ImageJ/Fiji and Adobe Photoshop.
Quantitative analysis of retinal vasculature. Single-low magnification (10× lens)
or tile merged high magnification (20× or 40× lens) confocal fields of the angio-
genic front or the mature vascular area were quantified with Fiji/ImageJ. Each
microscopy field contained hundreds of ECs, and the relative or absolute number
of cells in each field is indicated in the charts by a dot. As indicated in figure
legends, microscopy images from several animals and retinas (2 per animal) were
used for the phenotypic comparisons and quantifications. Vascular IsolectinB4+
area and Erg+, or Edu+ cells were quantified semiautomatically using custom Fiji
macros. EC density (EC number/mm2) was measured as the number of Erg+ cells
relative to the vascularised IsolectinB4+ area in each field. The frequencies of Erg+
cells (ECs) in S-phase (EdU+), in the cell cycle (KI67+), or p21+ were determined
as the ratio of double-positive cells to the total number of Erg+ cells per field. In
some experiments, these signals were quantified in images including membrane- or
chromatin-localised fluorescent proteins, enabling identification and quantification
of proliferation frequency and p21 expression in different subsets of mutant and
control cells.
Statistical analysis. Two groups of samples with a Gaussian distribution were
compared by unpaired two-tailed Student t test. Comparisons among more than
two groups were made by ANOVA followed by the Turkey pairwise comparison.
Graphs represent mean ± SD as indicated, and differences were considered sig-
nificant at p < 0.05. All calculations were done in Excel and final datapoints
analysed and represented with GraphPad Prism. No randomisation or blinding was
used, and animals or tissues were selected for analysis based on their genotype,
the detected Cre-dependent recombination frequency, and quality of multiplex
immunostaining. The sample size was chosen according to the observed statistical
variation and published protocols.
Reporting Summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data supporting the findings of this study are available from the corresponding author
upon request. This includes raw data such as unprocessed original pictures and
independent replicates, which are not displayed in the manuscript, but are included in
the data analysis in the form of graphs. The source data underlying all figures numeric or
chart data are provided as a Source Data file.
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Supplementary Fig. 1 Proliferative eect of Notch inhibition in vitro and validation of dierent pharmacological and 
genetic approaches used to interfere with Notch signalling. 
a) Inhibition of Notch signalling with DBZ for 24h increases the frequency of KI67+ HUVECs.  n=4 independent experi-
ments.
b) Inhibition of Notch signalling with DBZ for 24h in ECs derived from embryonic stem cells carrying a Rosa26knock-in 
FUCCI allele, increases the frequency of ECs (ICAM2+) in S/G2/M (Venus+). 
c) Diagram representing the iSuRe-Cre allele. After inducible CreERT2 recombination, cells express MbTomato and a intron 
containing Cre. 
d) Detection of the Rbpj oxed allele by PCR shows that deletion of the allele is complete in MbTomato+ cells collected by 
FACS from RbpjiKO-EC mutants. 
e) qRT-PCR of RNA collected from CD31-APC+ Retina ECs of Rbpjf/f (n=3) or RbpjiKO-EC mutants (n=3), shows the pronounced 
reduction in Rbpj mRNA levels in MbTomato+ cells.
f) Comparison by qRT-PCR of canonical endothelial Notch targets (Hey1 and Efnb2) expression in retina ECs collected by 
FACS from animals receiving DAPT (for 24h, n=3) or Anti-Dll4 (for 24h, n=3) or with induced Rbpj deletion for 5 days (n=3).
Error bars indicate StDev; NS, non-signicant; * p< 0.05; ** p<0.005 relative to control. Two-tailed unpaired T-test (a, e). 
One-way ANOVA with Tukey’s post hoc test (f ). Source data are provided as a Source Data le.
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 Supplementary Fig. 2
Supplementary Fig. 2 iChr-Notch-Mosaic constructs, mosaic ratios and canonical Notch target genes proling.
a, b) Diagram of iChr-Notch-Mosaic allele, with the distances between loxP sites and obtained frequencies in mouse ES 
cells after Cre plasmid transfection. 
c) Mice carrying the iChr-Notch-Mosaic and Tie2-Cre alleles have recombination of the construct between E8.0 and E8.5. 
FACS analysis of embryos at E9.5 (n=4) reveals the proportion of ECs expressing the dierent markers at that timepoint. 
Note the dierence between ES cells (a) and E9.5 embryos (c). 
d) The iChr-Notch-V2-Mosaic allele contains DN-Rbpj instead of DN-Maml1, and a change in the position  of the control 
cassette (Cerulean+), resulting in the lower occurrence of these cells.
e, f) Mice carrying the iChr-Notch-V2-Mosaic and Tie2-Cre alleles will have recombination of the construct between E8.0 
and E8.5. FACS analysis of animals at P20 reveals the proportion of ECs expressing the dierent markers at that timepoint. 
Note the dierence between the initial recombination ratio in ES cells (d) and in the vasculature of the dierent organs (e, 
f ). 
g, h) Comparison by qRT-PCR of canonical Notch targets expression in ECs collected by FACS from iChr-Notch-Mosaic 
(n=3) and RbpjiKO-EC animals (n=3).
Error bars indicate StDev; NS, non-signicant; * p< 0.05; ** p<0.005. One-way ANOVA with Tukey’s post hoc test (g) and 
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 Supplementary Fig. 3
Supplementary Figure 3. Temporal analysis of the proliferative eect of Notch inhibition in angiogenic and mature 
vessels  in vivo.  
a, b) Confocal micrographs of retinal vasculature from animals treated with IgG (control) and anti-Dll4 for 72h and immunos-
tained with anti-Erg (red signal, labels EC nuclei) and with EdU labelling in the nuclei of all cells in S-phase in the 4 h before 
dissection. Blue signal is EdU in the nuclei of non-endothelial (ERG-) cells, and green signal indicates ERG+/EdU+ endothelial 
nuclei (ERG+ Red and EdU+ Blue signals when colocalize result in pink color, that was pseudocolored to green to better 
highlight ECs in S-phase. Higher magnication pictures are provided to show the distinct eects of Dll4/Notch inhibition in 
the proliferative angiogenic front and in the mature/quiescent area.
c-f) Charts showing that Dll4/Notch signaling inhibition with anti-Dll4 for 72h leads to premature cell cycle exit at the angio-
genic front and cell cycle entry of quiescent/mature ECs, indicated by the changes in the frequency of Erg+ cells in S-phase 
(EdU+, green) observed in these two distinct areas. This results in an increased EC density in the mature vascular area. 
g, h) Similar analysis in animals treated with anti-Dll4 for only 12h indicates that at this stage there is not a signicant dier-
ence in EC density or the frequency of ECs in S-phase.
Charts show comparative analysis of large microscopy elds taken from 4 retinas per group. Error bars indicate SEM; NS, 
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Supplementary Figure 4. Eect of Notch inhibition on the frequency of endothelial cells in cycle (Ki67+) in angiogenic 
and mature vessels.
a) Diagram illustrating the mouse iChr-Cerulean/GFP allele used to specically label the nuclei of the endothelium with GFP 
and Cerulean proteins, in order to be possible to perform the co-immunostaining with rabbit anti-Ki67  and goat anti-GFP to 
detect the nuclei of ECs (we could not use the incompatible rabbit anti-ERG, that was combined with EdU in Sup. Fig. 3).
b-e) Confocal micrographs of retina vessels from animals carrying the Tie2-Cre and iChr-Cerulean/GFP reporter allele. In these 
mice, most ECs will express Cerulean or GFP in the nucleus, both recognized by the anti-GFP antibody. This allows detection 
in the same immunostaining of Ki67, present in all cycling cells. Yellow nuclei correspond to GFP+/Ki67+ cycling ECs and 
green nuclei to non-cycling ECs (GFP+/KI67-). Scale bars, 50µm.
f, g) Quantication of several microscopic elds as represented in b-e. Error bars indicate SEM; NS, non-signicant; * p< 0.05; 
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Supplementary Figure 5. ERK activity in mature ECs after Dll4/Notch inhibition or VEGFR2 activation.
a) Confocal micrographs of the mature retinal vasculature of control (n=3) and anti-Dll4 (n=4) treated animals, showing very 
low basal P-ERK levels in mature vessels (compare with Fig. 3a), that increase after Dll4/Notch signaling blockade for only 24h. 
However, P-ERK levels do not reach the very high level detected at the angiogenic front (compare with Fig. 3a right). 
b) Confocal micrographs of P6 retina vessels from animals (n=3) carrying the iMb-Vegfr2-Mosaic and Cdh5-CreERT2 alleles, 
three days after tamoxifen injection. Expression of MbTomato-2A-Vegfr2Ac (yellow arrows) induces a marked upregulation of 
P-ERK levels in endothelial cells. Each dot in the chart represents the average relative P-ERK signal in a single cell segmented 
area, in relation to the background signal in the IsolectinB4 negative area. 
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  Supplementary Fig. 6
Supplementary Fig. 6. Notch strongly represses the expression of tip cell enriched genes and Cdkn1a (p21) but not 
Vegfrs.
a) Confocal micrographs of the control and anti-Dll4 treated retinal vasculature stained with IsolectinB4.
b) Evaluation by qRT-PCR (n=3 independent experiments) of genes dierentially expressed by angiogenic retina vessels after 
anti-Dll4 (n=6 animals) or anti-VEGF (n=6 animals) treatment for 24h. Tip cells enriched genes and Cdkn1a (p21) are signicant-
ly regulated by Notch and VEGF in a opposite manner. 
c, d) Confocal micrographs of P7 retinas from iMb-Vegfr2-Mosaic Cdh5-CreERT2 mice, 4 days after inducing with tamoxifen the 
expression of MbYFP-2A-VEGFR2TkMut in some ECs, and 2 days after receiving control IgG or Anti-Dll4 for 48h. When 
Dll4/Notch signaling is inhibited, VEGFR2TKMut expressing mature ECs enter the cell cycle (KI67+, asterisk) and are able to 
proliferate. Note that there is some unspecic KI67 signals in the membrane of some cells. In higher magnication panels 
shown in 1 and 2  is possible to see a dierence in the morphology of MbYFP-2A-VEGFR2TkMut expressing cells induced by 
anti-Dll4 treatment.
Error bars indicate StDev in b and SEM in d; NS, non-signicant; * p< 0.05; ** p<0.005; *** p<0.0005. Two-tailed unpaired T-test. 



























































  Supplementary Fig. 7
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  Supplementary Fig. 7 Pontes-Quero et al.
Supplementary Figure 7.  A mouse line to label and genetically pulse ECs with high Esm1 expression.
a) Targeting vector and Esm1 allele genetic maps. To label the nuclei and induce genetic recombination in individual 
endothelial tip cells, we introduced the HA-H2B-Cerulean-2A-CreERT2-Sv40pA-FRT-Neo-FRT cassette in the Esm1 starting 
codon (ATG) by CRISPR/Cas9-induced double-strand break and homologous recombination-dependent repair. The donor 
vector contained two homology arms with 413 and 454bp, respectively, and was electroporated into ES cells. After selec-
tion in G418 (neomycin), the resistant clones were screened for correct vector integration, rst by PCR with the indicated 
primers and after by Southern blot with a labeled probe against the Neo gene. The FRT-Neo-FRT cassette was later ipped 
out by transient transfection of FlpO, and clones without Neo resistant cells were used to generate mice. 
b) Confocal micrographs from P7 retinas of mice with the above mentioned alleles and pulsed with tamoxifen at P3. In 
most retinas, there were either no labelled cells, or only 1 clone with labelled cells per ank (each dissected and 
at-mounted retina has 4 anks). Clones were of dierent sizes (see also Fig. 4c chart). Given the very low frequency of 
Tomato+ cells and their clonal and nearby distribution in the tissue, it is statistically highly improbable that clones with 
more than 2 cells arose from more than one independent stochastic tip-cell recombination event.
c) Representative confocal micrographs showing the 4 signals detected after immunostaining with the indicated antibod-
ies, of the postnatal day 6 mouse retina of Dual ifgMosaic mice, carrying the Cdh5-CreERT2 allele, and pulsed once with 
tamoxifen at P3. Magnied boxed areas (1 to 3) and two-letter codes show selected double-recombined cell clones and 
the observed combination of FPs A to F, at higher magnication. The chance of a given dual recombination event is lower 
than single recombination event, enabling the identication and quantication of single-cell derived clones (see also 
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Supplementary Figure 8. Single cells with a decrease in Notch signalling exit cell cycle and sprout more frequently.
a, b) Confocal micrographs of the angiogenic front of P6 retinas from animals expressing the iChr-Notch-Mosaic allele in 
endothelial cells (IsolectinB4+). Individual cells with lower Notch signalling (GFP+) are more frequently p21+, especially if 
they express GFP strongly and are at the leading edge of the vessels. Blue arrowheads indicate GFP+/p21+ cells. Pink 
arrowheads indicate Cherry+/p21+ cells.
c, d) Confocal micrographs of the angiogenic front of P6 retinas from animals expressing the iChr-Notch-Mosaic allele in 
endothelial cells (IsolectinB4+). Individual cells with lower Notch signalling (GFP+) are less frequently KI67+, especially if 
they express GFP strongly and are at the leading edge of the vessels.
e) Cells with a decrease in Notch signalling (GFP+), are more frequently found at the leading edge of the vessels.
Primer Name Primer Sequence PCR Ta Band Size Purpose
hVEGFR2 seq F GCGGCACGAAATATCCTCT
hVEGFR2 seq R ATTTCCCACAGCAAAACACC
CTP  PHI F ACGTGAAGCTGAGCAAGGAT
CTP H2B R CTTAGTCACCGCCTTCTTGG
LoxP3 seq F TCAATGTATCTTAAGGCGTGACT
mTFP1 R TACTTGGTGAAGGCCCTGTT
Esm1 Trans F CTCCGTGCTAAGGGACTCTG
H2B PCR REV  CCTTAGTCACCGCCTTCTTG
Esm1 WT F AACAAGAGAGGCTGGCAAGA
Esm1 WT R TCCATGCCTGAGACTGTACG
RR711 GCACTTGCTCTCCCAAAGTC 
RR713  CTTTAAGCCTGCCCAGAAGA 
CAG PCR F CGGGGTCATTAGTTCATAGCC
CAG PCR R CACCTCGACCATGGTAATAGC




Dll4 lox (Duarte) GTGCTGGGACTGTAGCCACT




60C 206bp To detect the iMb-VEGFR2-Mosaic allele
60C 550bp To detect the iChr-Mosaic allele
60C 600bp To detect the iMb-Mosaic allele
60C 350bp Mutant Band  300 bp Wt band  To detect Esm1 Knock-In
60C 350bp Mutant Band  250 bp Wt band  To detect Rosa26 Knock-in
60C 550bp To detect the VE-cadherin(Pac)-CreERT2 allele
60C 600bp KO band  760bp Wt band  To detect the p21 KO allele
60C 350bp Floxed band  200 bp Wt band  To detect the Rbpj floxed allele
60C 500bp Floxed band  400 bp Wt band  To detect the Dll4floxed allele
 Supplementary Table 1
Primers used to genotype mice
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